Your browser doesn't support javascript.
loading
Brief Introduction on the Disclosure of FDA Information in US and Its Implication / 中国药房
China Pharmacy ; (12)2005.
Article in Chinese | WPRIM | ID: wpr-532661
ABSTRACT

OBJECTIVE:

To provide reference for food & drug regulatory authorities in China to disclose government information.

METHODS:

In the light of the development and status quo of the disclosure of information in US FDA,the access,content and procedure for the disclosure of information in FDA were discussed.RESULTS &

CONCLUSIONS:

There are many similarities between US and China in the disclosure of information.In view of the practical situation of governmental information disclosure in food and drug regulatory authorities in China,Chinese government should be able to find out such key issues as the human and financial support is much needed in FDA information disclosure,the disclosure level should be in line with our national condition,a three-dimensional publicity system of government information at different level should be established and emphasis should be laid to the key disclosed information etc based on the research on the development,access,content and procedure of information disclosure in FDA.

Full text: Available Index: WPRIM (Western Pacific) Language: Chinese Journal: China Pharmacy Year: 2005 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Language: Chinese Journal: China Pharmacy Year: 2005 Type: Article